Latest filing published 01 Oct 2009 for Raptor Pharmaceutical Corp, €3,069.
Insider track record
No signal scores available.
Gimv NV: trading record in brief
All filings by Gimv NV on record concern Raptor Pharmaceutical Corp. Between 17 September 2009 and 21 September 2009, the trades on record add up to 9 filings.
On the market, this insider has only sold: 9 sales, €111k in total.
On 1 October 2009 came the latest disclosure, an open-market sale for €3,069 in Raptor Pharmaceutical Corp. Filings reach the SEC (Form 4) feed a median of 13 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gimv NV
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,710 shares@ US$0.2703Common stockSEC:0001284391-09-000003:2
- 244,699 shares@ US$0.2639Common stockSEC:0001284391-09-000003:3
- 30,702 shares@ US$0.2639Common stockSEC:0001284391-09-000003:4
- 75,689 shares@ US$0.2639Common stockSEC:0001284391-09-000003:5
- 137,715 shares@ US$0.2502Common stockSEC:0001284391-09-000003:6
- 17,211 shares@ US$0.2502Common stockSEC:0001284391-09-000003:7
- 42,430 shares@ US$0.2502Common stockSEC:0001284391-09-000003:8
- 54,022 shares@ US$0.2703Common stockSEC:0001284391-09-000003:0
- 6,778 shares@ US$0.2703Common stockSEC:0001284391-09-000003:1
9 of 9 declarations
